The world's first stem cell therapy for the treatment of an intractable disease ALS was developed in Korea
The world's first stem cell therapy for the treatment of an intractable disease ALS was developed in Korea. On July 30, biopharmaceutical company Corestem announced that they received sales approval of amyotrophic lateral sclerosis (ALS) treatment 'Neuronata-R Ⓡ' which they developed with Hanyang...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
